09:10 AM EDT, 05/14/2024 (MT Newswires) -- Health care stocks were steady premarket Tuesday as the iShares Biotechnology ETF ( IBB ) was inactive and the Health Care Select Sector SPDR Fund ( XLV ) was a slight 0.1% lower recently.

PTC Therapeutics ( PTCT ) shares were up more than 7% after the company said the US Food and Drug Administration granted priority review for its biologics license application for gene therapy Upstaza.

Profound Medical ( PROF ) shares were over 8% higher after the company said it received US Food and Drug Administration clearance for its TULSA-AI Contouring Assistant for use with its TULSA-PRO system to treat prostate disease.

HealthEquity ( HQY ) said it completed its acquisition of BenefitWallet from Conduent ( CNDT ) . HealthEquity ( HQY ) shares were over 2% lower pre-bell.